Case Report of Patient with Relapse of B-cell Lymphoma in the Breast Parenchyma.

D. Grebić, P. V. Zujic, N. Trbojević
{"title":"Case Report of Patient with Relapse of B-cell Lymphoma in the Breast Parenchyma.","authors":"D. Grebić, P. V. Zujic, N. Trbojević","doi":"10.7727/wimj.2014.190","DOIUrl":null,"url":null,"abstract":"We present a patient with relapse of B-cell non-Hodgkin's lymphoma in the breast that was clinically presented as a primary breast cancer. A 72-year old female was treated with chemotherapy and monoclonal antibodies (anti-CD20) due to diffuse large B-cell non-Hodgkin's lymphoma. Complete remission was achieved. Three years later, she was presented with a palpable left breast lump in the perimammillar area of the left breast, dimensions up to 3 cm. Laboratory results were within normal range. Mammography re-vealed a solitary, bilobulated, non-calcified mass of the left breast. On ultrasound, the lesion was hypo-echoic with blurred edges, with posterior acoustic enhancement, measuring 2 × 3 × 7 × 2 cm. Histological findings of ultrasound-guided fine needle aspiration and core needle biopsy were corre-spondent to diffuse large B-cell lymphoma. Pathohistological report showed cells with CD20+/Bcl- 2+/Bcl-6-/MUM-1+/CD3- imunophenotype. The breast parenchyma was infiltrated with B-cell lym-phoma. After diagnosis was confirmed, radiotherapy was initiated. Repeat ultrasound studies showed complete regression of the left breast lesion as did positron emission tomography- computed tomography (PET/CT) scan three months after therapy. In conclusion, the relapse of lymphoma in the breast is very rare. In patients previously treated for lymphoma, differential diagnosis should always include relapse, although it clinically presents itself as a primary breast cancer.","PeriodicalId":104133,"journal":{"name":"The West Indian medical journal","volume":"133 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The West Indian medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7727/wimj.2014.190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We present a patient with relapse of B-cell non-Hodgkin's lymphoma in the breast that was clinically presented as a primary breast cancer. A 72-year old female was treated with chemotherapy and monoclonal antibodies (anti-CD20) due to diffuse large B-cell non-Hodgkin's lymphoma. Complete remission was achieved. Three years later, she was presented with a palpable left breast lump in the perimammillar area of the left breast, dimensions up to 3 cm. Laboratory results were within normal range. Mammography re-vealed a solitary, bilobulated, non-calcified mass of the left breast. On ultrasound, the lesion was hypo-echoic with blurred edges, with posterior acoustic enhancement, measuring 2 × 3 × 7 × 2 cm. Histological findings of ultrasound-guided fine needle aspiration and core needle biopsy were corre-spondent to diffuse large B-cell lymphoma. Pathohistological report showed cells with CD20+/Bcl- 2+/Bcl-6-/MUM-1+/CD3- imunophenotype. The breast parenchyma was infiltrated with B-cell lym-phoma. After diagnosis was confirmed, radiotherapy was initiated. Repeat ultrasound studies showed complete regression of the left breast lesion as did positron emission tomography- computed tomography (PET/CT) scan three months after therapy. In conclusion, the relapse of lymphoma in the breast is very rare. In patients previously treated for lymphoma, differential diagnosis should always include relapse, although it clinically presents itself as a primary breast cancer.
乳腺实质b细胞淋巴瘤复发1例报告。
我们提出一个患者复发的b细胞非霍奇金淋巴瘤在乳房,临床表现为原发性乳腺癌。一位72岁的女性因弥漫性大b细胞非霍奇金淋巴瘤而接受化疗和单克隆抗体(抗cd20)治疗。完全缓解。三年后,她在左乳乳周发现一个可触及的肿块,大小达3cm。实验室结果在正常范围内。乳房x光检查显示左乳房单发、双叶状、非钙化肿块。超声示病灶低回声,边缘模糊,后侧声增强,大小为2 × 3 × 7 × 2 cm。超声引导下细针穿刺和芯针活检的组织学表现符合弥漫性大b细胞淋巴瘤。病理组织学报告显示细胞具有CD20+/Bcl- 2+/Bcl-6-/MUM-1+/CD3-免疫表型。乳腺实质浸润b细胞淋巴瘤。确诊后开始放疗。重复超声检查显示左乳房病变完全消退,正电子发射断层扫描-计算机断层扫描(PET/CT)治疗后三个月。总之,乳腺淋巴瘤的复发是非常罕见的。在既往接受淋巴瘤治疗的患者中,鉴别诊断应包括复发,尽管它在临床上表现为原发性乳腺癌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信